Enabling Cellular Delivery of Therapeutics
Oncology Solutions at the Cellular Level
Past and Present
More than 100 Issued Patents
Disruptive Platform Technology
More than 100 Issued Patents
Decades of Research
Disruptive Platform Technology
More than 100 Issued Patents
Disruptive Platform Technology
Disruptive Platform Technology
Disruptive Platform Technology
LEADERSHIP
Gary Strange, Chairman of the Board and Founder
Gary Strange, Chairman of the Board and Founder
Gary Strange, Chairman of the Board and Founder
Gary has 30+ years' experience working with businesses from start up to exit. He is a visionary that brought LifePulse from concept to reality in four years.
Franck Carlier CEO
Gary Strange, Chairman of the Board and Founder
Gary Strange, Chairman of the Board and Founder
Former Global CIO at Eurofins & Essilor
Led 3,500+ employees, managing $400M+ budgets.
CEO of VisionWeb, scaled $28M business, drove 20% YoY growth.
Led $16M cost savings, grew shared services revenue from $3.7M to $18M.
M.Eng. in Information Systems, Executive MBA, French Military Sergeant.
Gerald Sokol, MD CMO
Gary Strange, Chairman of the Board and Founder
Dr Loree Heller CSO
Dr Sokol has multiple boarding in oncology and decades of experience in FDA clinical trials.
Dr Loree Heller CSO
Roger Jackson, CPA CFO
Dr Loree Heller CSO
Over 40 years' experience in the sciences.
PhD in molecular biology
Roger Jackson, CPA CFO
Roger Jackson, CPA CFO
Roger Jackson, CPA CFO
Roger has more than 20 years' experience with the financials of medical device companies
SCIENCE AND FINANCIAL LEADERSHIP
Dr. Richard Heller, CSO
Chelsea Tripp, DVM, ACVIM, Oncology
Dr. Mark Jaroszeski, VP Research
Dr Heller is the preeminent scientist worldwide for electroporation based technologies and Fellow of the National Inventors Hall of Fame
Dr. Mark Jaroszeski, VP Research
Chelsea Tripp, DVM, ACVIM, Oncology
Dr. Mark Jaroszeski, VP Research
Dr Jaroszeski has worked side by side with Dr Heller for more than three decades and is also a Fellow of the National Inventors Hall of Fame
Chelsea Tripp, DVM, ACVIM, Oncology
Chelsea Tripp, DVM, ACVIM, Oncology
Chelsea Tripp, DVM, ACVIM, Oncology
Dr Tripp is the most recognized expert for this type of technology in veterinary medicine and is a sought-after speaker and key opinion leader
Alexander Fleming, MD
Chelsea Tripp, DVM, ACVIM, Oncology
Chelsea Tripp, DVM, ACVIM, Oncology
A physician by training, Dr Fleming is the founder of Kinexum, a highly respected FDA translational guidance firm based in Washington, DC
HUMAN HEALTH
Our History
Our pre-submission to the FDA to use the 510k pathway quickly received a positive response. Listed as an unmet need in a joint NIH/FDA study in 2018, we believe this will result in a swift clearance sometime in early 2026 with clinical trials to follow.
Our Patents
LifePulse is the recipient of more than $35M and decades of R&D that are undiluted investment in the company. This has allowed us to build a fortress of patents surrounding every aspect of our technology.
Our Mission
We are dedicated to make this life changing technology available to the US first, and then the world. The worldwide unmet need is staggering for this disruptive technology. Beginning with pancreatic tumor trials in 2026, we boldly go to change outcomes for the terminally ill.
Animal Health Division
LifePulse Bioscience
Since March, 2022 hundreds of dogs, cats and horses have been successfully treated for dozens of indications. Our veterinary devices are now in clinical use throughout the US and soon abroad. For more information visit our Animal Health website (lifepulsebio.com)
US Engineered and Manufactured Platform Technology
Changing Outcomes for our Pets and Working Animals
VetPulse 2000
With robust sales in both veterinary oncology, equine hospitals, universities and an international distribution agreement with Patterson Veterinary, LifePulse is the leader in PEF for veterinary medicine.
Join Us
Fight Targeted Disease
Research of therapeutics using cellular delivery is going to change outcomes for millions of patients. Therapeutic delivery at the cellular level in this manner is a game changer in medicine.
Contact Us
Located in the Tampa Bay Medical Park
For clinical trial information contact us at
LifePulse Corporation
